H.C. Wainwright Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Maintains Target Price $9
Caribou Biosciences Analyst Ratings
Caribou Biosciences Analyst Ratings
RBC Capital Reiterates Outperform on Caribou Biosciences, Maintains $14 Price Target
Strategic Focus and Financial Runway Extension Bolster Caribou Biosciences' Buy Rating
Caribou Biosciences Analyst Ratings
Caribou Biosciences Analyst Ratings
Evercore ISI Downgrades Caribou Biosciences to In-Line Rating With $3 Price Target
Analysts Conflicted on These Healthcare Names: AstraZeneca (GB:AZN), Sartorius (GB:0NIR) and Caribou Biosciences (CRBU)
Caribou Biosciences Analyst Ratings
Truist Financial Releases a Buy Rating on Caribou Biosciences (CRBU)
Caribou Biosciences Analyst Ratings
Caribou Biosciences (CRBU) Receives a Buy From Bank of America Securities
Analysts' Opinions Are Mixed on These Healthcare Stocks: Caribou Biosciences (CRBU) and Mettler-Toledo (MTD)
Analysts' Top Healthcare Picks: Caribou Biosciences (CRBU), Lineage Therap (LCTX)
Analysts Are Bullish on These Healthcare Stocks: Bio-Rad Laboratories (BIO), Caribou Biosciences (CRBU)
Analysts Offer Insights on Healthcare Companies: 3SBio (OtherTRSBF), UnitedHealth (UNH) and Caribou Biosciences (CRBU)
Analysts Are Bullish on Top Healthcare Stocks: Paragon 28 (FNA), Caribou Biosciences (CRBU)
HC Wainwright Adjusts Caribou Biosciences Price Target to $24 From $23, Maintains Buy Rating
Analysts' Opinions Are Mixed on These Healthcare Stocks: Fusion Pharmaceuticals (FUSN), Caribou Biosciences (CRBU) and Neurogene (NGNE)